The Department of Psychiatry at the University of Oxford will conduct an international study to investigate whether cannabis-based medicine can treat psychosis.
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a developer of cannabinoid-based medicines, will conduct FDA Phase 2 and Phase 3 clinical trials for its HOPE-1 treatment of Autism Spectrum Disorder (ASD).
Cantor Fitzgerald’s Pablo Zuanic initiated research coverage of Verano Holdings Corp. (OTCQX: VRNOF), Ascend Wellness Holdings, Inc. (OTCQX: AAWH), and Planet 13 Holdings I
Whether you've got a special significant other, good friend, or relative, or if you want to make yourself especially happy this Valentine's Day, we've put together a gift guide for those extraordinary people in your lives.
Smart & Safe Florida political committee filed a measure this past summer proposing a constitutional amendment to legalize recreational marijuana. The proposal received enough signatures for the measure to be reviewed by the Florida Supreme Court and now seeks to be placed on the 2024 ballot.
Late Tuesday, Origin Therapeutics Holdings Inc. (CSE: ORIG), an investment issuer that has historically focused on psychedelics-industry-related companies announced it had signed a binding Letter of Intent (LOI) to acquire all of the issued and outstanding securities of Safe Supply Streaming Co., a pharmaceutical streaming and investment company in the safe supply eco
Vertically integrated cannabis operator, Stem Holdings, Inc. (OTCQB: STMH, CSE: STEM) announced that executed a term sheet for a proposed business combination with Headwaters, LLC, a California-based greenhouse cultivator.
MariMed, Inc. (OTCQX: MRMD), a leading multi-state cannabis operator, announced it closed a $35 million secured credit facility with Chicago Atlantic Advisors, LLC as the lead lender.